| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0265500B1 Antibody to human progesterone receptor and diagnostic materials and methods |
| 08/16/1994 | US5338833 Carboxy terminal IL-6 muteins |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994017185A1 G-csf analog compositions and methods |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/02/1994 | US5334391 Intracellularly cleavable compounds |
| 08/02/1994 | US5334379 Cytokine and hormone carriers for conjugate vaccines |
| 08/02/1994 | CA2113669A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone h1, and uses therefor |
| 07/27/1994 | EP0607368A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0399001B1 T-cell epitope as carriers molecule for conjugate vaccines |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | CA1330961C Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994015968A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2151597A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
| 07/20/1994 | EP0606430A1 Chimeric anti-cea antibody |
| 07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 07/19/1994 | US5330910 Immunoassay |
| 07/19/1994 | US5330754 Membrane-associated immunogens of mycobacteria |
| 07/13/1994 | EP0605797A1 Synthetic peptides, antibodies directed against them and their use |
| 07/13/1994 | EP0605789A1 Characterization of oncogenes and assays based thereon |
| 07/13/1994 | EP0605522A1 Production of chimeric antibodies - a combinatorial approach |
| 07/13/1994 | EP0563296A4 Optimization of binding proteins |
| 07/07/1994 | WO1994015028A1 Runway-maintenance device |
| 07/07/1994 | WO1994014960A2 Protocadherin, their autibodies and uses |
| 07/07/1994 | WO1994014848A1 Genetically engineered immunoglobulins |
| 07/07/1994 | WO1994014847A1 Genetically engineered immunoglobulins |
| 07/07/1994 | WO1994014467A1 Treatment of inflammatory bowel disease with ifn-gamma inhibitors |
| 07/07/1994 | WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity |
| 07/06/1994 | EP0604584A1 Factors for the cellular functional regulation and biological applications thereof |
| 07/06/1994 | EP0374157B1 A new class of low calorie protein sweeteners |
| 07/06/1994 | CN1025350C Method for promoting formation of inner molecular disulfide bond of recombination protein in solution of denaturing agent |
| 07/05/1994 | US5326559 Treatment of accelerated atheosclerosis with interleukin-2 receptor targeted molecules |
| 06/29/1994 | EP0604224A1 Porcine GRF receptor |
| 06/29/1994 | EP0603735A2 Monoclonal antibodies that define a unique antigen of human B-cell antigen receptor complex |
| 06/29/1994 | EP0245362B1 Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 06/28/1994 | CA1330420C Compositions containing growth hormone peptide fragments |
| 06/23/1994 | WO1994013818A1 Identification of compounds modulations protein/cell membrane association |
| 06/23/1994 | WO1994013817A1 Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 06/23/1994 | WO1994013812A2 Novel entomopoxvirus genes, proteins and methods of use thereof |
| 06/23/1994 | WO1994013808A2 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 06/23/1994 | WO1994013806A1 Multivalent single chain antibodies |
| 06/23/1994 | WO1994013805A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | WO1994013804A1 Multivalent and multispecific binding proteins, their manufacture and use |
| 06/23/1994 | CA2150249A1 Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof |
| 06/23/1994 | CA2128544A1 Humanised antibodies directed against a33 antigen |
| 06/23/1994 | CA2112018A1 Porcine grf receptor |
| 06/23/1994 | CA2110852A1 Monoclonal antibodies that define a unique antigen of human b cell receptor complex and methods of using same for diagnosis and treatment |
| 06/22/1994 | EP0602899A2 Modified proteins containing controllable intervening sequences and methods of their production |
| 06/22/1994 | EP0602688A1 Methionine free G-CSf from prokaryotes |
| 06/22/1994 | EP0602126A1 Immunoglobulin variants for specific fc epsilon receptors |
| 06/22/1994 | EP0602079A1 POLYPEPTIDES CAPABLE OF $i(IN VIVO) INDUCTION OF ANTIBODIES THEMSELVES CAPABLE OF INHIBITING THE INVASION OF RED BLOOD CORPUSCLES BY MEROZOITES OF $i(P.FALCIPARUM), RELATED PRODUCTS AND THEIR USE IN PRODUCING VACCINE COMPOSITIONS |
| 06/22/1994 | EP0486525B1 Stabilized protein or peptide conjugates |
| 06/22/1994 | EP0176588B1 Platelet related growth regulator |
| 06/21/1994 | US5322930 Fusion protein containing carrier protein with peptide fused to cleavage site; high isoelectric point facilitates separation |
| 06/21/1994 | US5322769 Methods for using CKS fusion proteins |
| 06/15/1994 | EP0601360A1 Progenitor B cell stimulating factor |
| 06/15/1994 | EP0601135A1 Osteogenic proteins in the treatment of bone diseases |
| 06/15/1994 | EP0601125A1 V$g(a)12.1 T-CELL RECEPTOR-SPECIFIC REAGENTS FOR DIAGNOSING AND TREATING RHEUMATOID ARTHRITIS |
| 06/15/1994 | EP0601043A1 Hybrid cytokines |
| 06/15/1994 | EP0600866A1 Compositions and methods for identifying biologically active molecules |
| 06/09/1994 | WO1994012631A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | WO1994012535A1 Progenitor b cell stimulating factor |
| 06/09/1994 | WO1994012529A1 Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome |
| 06/09/1994 | WO1994012526A1 PURIFICATION OF FUSION PROTEINS COMPRISING GM-CSF and IL-3 |
| 06/09/1994 | CA2149763A1 Progenitor b cell stimulating factor |
| 06/09/1994 | CA2149635A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors |
| 06/09/1994 | CA2148935A1 Purification of fusion proteins comprising gm-csf and il-3 |
| 06/08/1994 | EP0600372A1 Process for the preparation of proinsulin with correctly linked cystin bridges |
| 06/08/1994 | EP0600018A1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 06/08/1994 | EP0600009A1 Hepatitis c assay utilizing recombinant antigens to ns1 |
| 06/08/1994 | EP0600000A1 Hepatitis c assay utilizing recombinant antigens from ns5 region |
| 06/08/1994 | EP0599913A1 Monoclonal antibodies to putative hcv ns5 proteins and methos for using same |
| 06/07/1994 | US5318958 Administering complex of high density lipoprotein and ligand having serum amyloid affinity for high density lipoproteins and promoting macrophage release of cholesterol for elimination |
| 06/01/1994 | EP0598816A1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/01/1994 | EP0172865B2 Dna sequences, recombinant dna and processes for producing antigens of plasmodium falciparum |
| 05/31/1994 | US5317089 Monoclonal antibodies against IFN-omega, processes for preparing them and their use in the purification and detection of IFN-omega |
| 05/26/1994 | WO1994011509A2 Peptides and anti-sense peptides with broad neoplastic specificity |
| 05/26/1994 | WO1994011504A1 C-c ckr-1, c-c chemokine receptor |
| 05/26/1994 | WO1994011384A1 Novel cytokine designated elk ligand |
| 05/26/1994 | WO1994002510A3 Analogs of pth |
| 05/26/1994 | WO1994001558A3 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 05/26/1994 | CA2148484A1 Novel cytokine designated elk ligand |
| 05/25/1994 | EP0597960A1 Treatment of cell populations |
| 05/25/1994 | EP0597845A1 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2 |
| 05/25/1994 | EP0597844A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
| 05/25/1994 | EP0597843A1 16 kDa SURFACE PROTEIN OF $i(P. FALCIPARUM) |